The CyberKnife G4 Program addresses the unique issues of random and extreme target motion through the use of intelligent and adaptive picture guidance, which minimizes dosage to surrounding healthy cells and critical structures, ultimately minimizing treatment problems and side effects. ‘This is an important milestone for Accuray as we continue our journey to expand the global footprint of our best-in-class radiosurgery treatment, the CyberKnife System,’ said Euan S. Thomson, Ph.D., president and CEO of Accuray.Cells were transfected with these reporter constructs and with pRL-TK renilla luciferase vector as a normalization control with the use of the FuGENE 6 transfection reagent . Relative luciferase activity of mock and GLCCI1 reporter constructs was calculated as the ratio of firefly luciferase activity to renilla luciferase. Reporter assays had been analyzed by using Student’s t-test. Electrophoretic Mobility-Shift Assay An electrophoretic mobility-shift assay was performed by using Gel Change Assay Systems according to the manufacturer’s instructions. Statistical Analysis FBAT is robust with respect to population stratification.32 This composite phenotype was used in the genomewide association research.